Skip to content

User evaluation of the 'free style Navigator continuous glucose monitoring system

User evaluation of the 'free style Navigator continuous glucose monitoring system - Navigator continuous glucose monitoring system

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON31154
Enrollment
20
Registered
2007-11-06
Start date
2009-06-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes mellitus

Interventions

The intervention is the use of the 'free style navigator continuous glucose monitoring device' with an number of facilities: 1: 'On line' display of the glucose level in the insterstitial fluid ever

Sponsors

Abbott
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Type 1 diabetes mellitus since at least 2 jaar Age at least 18 years

Exclusion criteria

Exclusion criteria: 1: Severe hypoglycaemia during the last 4 months before the start of the study 2: Medical problems (co-morbidity, organ complications of diabetes) of medication that would potentially jeopardize the participation of the patient in the eyes of the treating physician and/or the investigator 3: Pregnancy or planned pregnancy during the study period 4: Participation in another study with a comparable device

Design outcomes

Primary

MeasureTime frame
Primary study outcome is the degree of glycaemic variability, comparing the blinded period (days 0 tot 20) with the open period (days 20 to 60). Glucose variability is a mathematical outcome, derived from the glucose data from the first and second period of the Navigator-device. This outcome parameter is exemplified on page 27 of the protocol.

Secondary

MeasureTime frame
Secondary outcome parameter is the experiences of the users with this new device. Patients fill in a questionnaire after completion of the study.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)